MAR 18, 2015 12:41 PM PDT

Tiny Diamonds--A Cancer Cell's Best Friend?

WRITTEN BY: Will Hector
Cancer stem cells often cause tumors to form and are particularly difficult to destroy. They resist chemotherapy, allowing cancer to return.

But scientists say it may be possible to kill those stem cells by attaching a chemo drug to nanodiamonds.
Nanodiamonds found to kill cancer stem cells.
They tested this idea using the commonly used chemo drug Epirubicin, which they attached to nanodiamonds, carbon structures with a diameter of about five nanometers, to develop a nanodiamond-Epirubicin drug delivery complex (EPND).

The researchers found that while both standard Epirubicin as well as EPND were capable of killing normal cancer cells, only EPND was capable of killing chemoresistant cancer stem cells and preventing secondary tumor formation in xenograft models of liver cancer.

The study was published in ACS Nano and led by Edward Chow, assistant professor at the National University of Singapore.

Compared to other approaches, delivery of existing chemotherapy drugs with nanomaterials provide a broader range of protection in a package that is both safer and more effective.

The findings show that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage.

As such, delivery of chemotherapy drugs by nanodiamonds not only enables enhanced killing of chemoresistant cancer stem cells, but may be a useful alternative for patients who cannot tolerate the toxic side effects of standard chemotherapy drugs.

Researchers say this approach is not limited to liver cancer and could potentially treat other cancers driven by resistant stem cells.

Source: National University of Singapore
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
MAR 19, 2020
Cancer
MAR 19, 2020
Declining death rates for melanoma
Fewer people are dying from melanoma in the United States, suggests new research from the Perlmutter Cancer Center at NY ...
MAR 18, 2020
Drug Discovery & Development
MAR 18, 2020
Drug Could Effectively Treat a Lethal Blood Cancer
A pricey drug, called tyrosine kinase inhibitor (TKI), is used to continuously treat the blood cancer Chronic Myeloid Le ...
APR 06, 2020
Immunology
APR 06, 2020
Clearing the Path for Dendritic Cells to Eliminate Tumors
  Dendritic cells are the sentinels of the immune system and use their “tree-like” projections to prese ...
APR 27, 2020
Cancer
APR 27, 2020
The Tumor Suppressor and its Regulator: An Indirect Oncogene
Oncogenes, mutations in genes that promote cancer growth, have long been easy targets for cancer research due to the dir ...
MAY 07, 2020
Cancer
MAY 07, 2020
Yet Another Cancer Linked Tyrosine Kinase
In a cell, there are tens of thousands of individual components. Each component has a specific activity or role that the ...
JUN 02, 2020
Cancer
JUN 02, 2020
Gene identified that turn offs triple negative breast cancer
Breast cancer continues to ravage the US, with about one in eight women being diagnosed with the disease in her lifetime ...
Loading Comments...